Regulus Therap (RGLS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Jun25

Novartis Offer to Acquire Regulus Therapeutics Inc. Shares

05:17

Jun5

Preston Klassen Increases Holdings in Regulus Therapeutics Inc. Stock

11:59

Jun2

Regulus Therapeutics Inc. short interest significantly decreases

18:56

May22

Velan Capital Invests in Regulus Therapeutics

10:01

May20

Regulus Therapeutics Receives Diverse Ratings and Reports Earnings

07:17

May9

Regulus Therap released FY2025 Q1 earnings on May 8 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1455 (forecast USD -0.245)

03:00

Schedules & Filings

Schedules

Filings

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.634 M, EPS -0.1455

Mar13

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -12.79 M, EPS -0.1952

Nov7

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Net Income -14.06 M, EPS -0.2147

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change